Dokumentuaren aipamena

APA (7th ed.) Zitazioa
Jeffrey L. Goldberg, M., Gala Beykin, M., Kellie R. Satterfield, M., Mariana Nuñez, M., Byron L. Lam, M., & Thomas A. Albini, M. (2023). Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma. Elsevier.
Chicago Style (17th ed.) Zitazioa
Jeffrey L. Goldberg, MD, MD Gala Beykin, MD Kellie R. Satterfield, MD Mariana Nuñez, MD Byron L. Lam, eta MD Thomas A. Albini. Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma. Elsevier, 2023.
MLA (9th ed.) Zitazioa
Jeffrey L. Goldberg, MD, et al. Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma. Elsevier, 2023.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.